/

Other

/

Neurelis, Inc.

Neurelis, Inc.

Neurelis, Inc.

Verified Nov 2026

Other

·

United States flag

San Diego, California

·

Since 2007

Neurelis is a biotechnology company headquartered in San Diego, California, founded in 2007. With 200–500 employees and estimated revenue of $250–500 million, the private firm develops therapeutics for neurological conditions, particularly epilepsy and central nervous system disorders. Its flagship product VALTOCO® is an FDA-approved nasal spray formulation of diazepam for acute seizure cluster treatment in patients aged 2 years and older, utilizing proprietary drug delivery technology.

Neurelis, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2007

Headquarters

United States flag

San Diego, California

Employees

200-500

Ownership

Neurelis, Inc. at a glance

Revenue

$250-500M

Est. band

Employees

200-500

Founded

2007

Headquarters

San Diego, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Neurelis is a biotechnology company headquartered in San Diego, California, founded in 2007. With 200–500 employees and estimated revenue of $250–500 million, the private firm develops therapeutics for neurological conditions, particularly epilepsy and central nervous system disorders. Its flagship product VALTOCO® is an FDA-approved nasal spray formulation of diazepam for acute seizure cluster treatment in patients aged 2 years and older, utilizing proprietary drug delivery technology.

At a glance

Attribute

Detail

Founded

2007

Headquarters

San Diego, California

Employees

200-500

Revenue

$250-500M (estimated)

What Neurelis, Inc. makes

Neurelis develops FDA-approved therapies using proprietary nasal drug delivery technology and intravail formulation systems to address unmet needs in seizure and CNS disorder treatment.

Latest developments

Company details

The company is privately held and employs between 200 and 500 staff members. Neurelis, Inc. was founded in 2007, has an estimated 200-500 employees, and is headquartered in San Diego, California.

Frequently asked questions

What does Neurelis, Inc. do?

Neurelis is a biotechnology company headquartered in San Diego, California, founded in 2007. With 200–500 employees and estimated revenue of $250–500 million, the private firm develops therapeutics for neurological conditions, particularly epilepsy and central nervous system disorders. Its flagship product VALTOCO® is an FDA-approved nasal spray formulation of diazepam for acute seizure cluster treatment in patients aged 2 years and older, utilizing proprietary drug delivery technology.

Where is Neurelis, Inc. headquartered?

Neurelis, Inc. is headquartered in San Diego, California (3430 Carmel Mountain Rd, San Diego, California, 92121-1067).

When was Neurelis, Inc. founded?

Neurelis, Inc. was founded in 2007.

How big is Neurelis, Inc.?

Neurelis, Inc. has an estimated 200-500 employees, with revenue in the $250-500M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

San Diego, California (HQ)Headquarters · United States
San Diego, California (HQ)3430 Carmel Mountain Rd, San Diego, California, 92121-1067, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.